| pubmed-article:16877727 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0026985 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:16877727 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:16877727 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:16877727 | pubmed:dateCreated | 2006-7-31 | lld:pubmed |
| pubmed-article:16877727 | pubmed:abstractText | The risk factors for treatment-related myelodysplastic syndrome (t-MDS) and acute myelogenous leukemia (AML) after autologous stem-cell transplantation (ASCT) are similar to those that increase the risk of difficult stem-cell harvests. We reviewed our experience in 526 patients with lymphoma treated by ASCT to determine whether difficult stem-cell harvests predict for an increased risk of t-MDS/AML. | lld:pubmed |
| pubmed-article:16877727 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16877727 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16877727 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16877727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16877727 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16877727 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16877727 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:RybickiLisaL | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:SobecksRonald... | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:BolwellBrianB | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:KalaycioMattM | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:PohlmanBradB | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:AndresenSteve... | lld:pubmed |
| pubmed-article:16877727 | pubmed:author | pubmed-author:KuczkowskiEli... | lld:pubmed |
| pubmed-article:16877727 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16877727 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16877727 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16877727 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16877727 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16877727 | pubmed:pagination | 3604-10 | lld:pubmed |
| pubmed-article:16877727 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:meshHeading | pubmed-meshheading:16877727... | lld:pubmed |
| pubmed-article:16877727 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16877727 | pubmed:articleTitle | Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia. | lld:pubmed |
| pubmed-article:16877727 | pubmed:affiliation | Department of Hematology, The Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland, OH, USA. kalaycm@ccf.org | lld:pubmed |
| pubmed-article:16877727 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16877727 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16877727 | lld:pubmed |
